UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 277

Sortiert nach

Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: Analyzing patterns of progression in 285 patients

Hepatology (Baltimore, Md.), 2012-05, Vol.55 (5), p.1432-1442

2012

Link zum Volltext

Verfügbarkeit prüfen

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Journal of surgical oncology, 2019-07, Vol.120 (1), p.85-92

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-06, Vol.317 (23), p.2392

2017

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2014-05, Vol.32 (13), p.1365-1383

2014

Link zum Volltext

Verfügbarkeit prüfen

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Journal of clinical oncology, 2017-02, Vol.35 (4), p.446-464

2017

Link zum Volltext

Verfügbarkeit prüfen

An update on pharmacotherapies for colorectal cancer: 2023 and beyond

Expert opinion on pharmacotherapy, 2024, Vol.25 (1), p.91-99

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Metastatic Colorectal Cancer: ASCO Guideline

Journal of clinical oncology, 2023-01, Vol.41 (3), p.678-700

2023

Link zum Volltext

Verfügbarkeit prüfen

Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4465-4470

2013

Link zum Volltext

Verfügbarkeit prüfen

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2654-2668

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials as a path toward equity

Cancer, 2021-10, Vol.127 (20), p.3717-3719

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

The oncologist (Dayton, Ohio), 2017-03, Vol.22 (3), p.243-e23

2017

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma

The oncologist (Dayton, Ohio), 2017-03, Vol.22 (3), p.241-e15

2017

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4105-4112

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Journal of clinical oncology, 2012-12, Vol.30 (35), p.4344-4351

2012

Link zum Volltext

Verfügbarkeit prüfen

Disparities in gastrointestinal cancers

Journal of the National Medical Association, 2023-05, Vol.115 (2), p.S13-S18

2023

Link zum Volltext

Verfügbarkeit prüfen

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

Archives of pathology & laboratory medicine (1976), 2016-12, Vol.140 (12), p.1345-1363

2016

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer

Journal of clinical oncology, 2010-01, Vol.28 (3), p.493-508

2010

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1539-1544

2007

Link zum Volltext

Verfügbarkeit prüfen

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

Clinical gastroenterology and hepatology, 2013-10, Vol.11 (10), p.1358-1365.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2011-02, Vol.140 (2), p.497-507.e2

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Clinical cancer research, 2012-02, Vol.18 (3), p.890-900

2012

Link zum Volltext

Verfügbarkeit prüfen

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2008-04, Vol.299 (16), p.1914

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1359-1369

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203

Journal of clinical oncology, 2010-06, Vol.28 (18), p.2947-2951

2010

Link zum Volltext

Verfügbarkeit prüfen

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer

JNCI : Journal of the National Cancer Institute, 2015-01, Vol.107 (1), p.345-345

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(197)

Publikationsform

Artikel
(277)

Sprache

Englisch
(277)
Japanisch
(39)

Erscheinungsjahr

n.n

Thema

Humans
(255)
Life Sciences & Biomedicine
(217)
Science & Technology
(217)
Oncology
(176)
Female
(128)
Male
(123)
Middle Aged
(110)
Biological And Medical Sciences
(103)
Medical Sciences
(102)
Aged
(97)
Adult
(78)
Tumors
(72)
Treatment Outcome
(64)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(61)
Neoplasm Staging
(57)
Gastroenterology. Liver. Pancreas. Abdomen
(50)
Pharmacology. Drug Treatments
(45)
Chemotherapy
(44)
Aged, 80 And Over
(42)
Fluorouracil - Administration & Dosage
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: Analyzing patterns of progression in 285 patients

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

An update on pharmacotherapies for colorectal cancer: 2023 and beyond

Treatment of Metastatic Colorectal Cancer: ASCO Guideline

Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Clinical trials as a path toward equity

A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Disparities in gastrointestinal cancers

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer

Suchergebnisse filtern